Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,593 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas.
Goodman AM, Holden KA, Jeong AR, Kim L, Fitzgerald KD, Almasri E, McLennan G, Eisenberg M, Jahromi AH, Hoh C, Hurley M, Mulroney C, Tzachanis D, Ball ED, Jensen TJ, Kurzrock R. Goodman AM, et al. Among authors: kim l. Transplant Cell Ther. 2022 Jan;28(1):30.e1-30.e7. doi: 10.1016/j.jtct.2021.10.007. Epub 2021 Oct 13. Transplant Cell Ther. 2022. PMID: 34655803 Free article.
Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer Patients.
Jensen TJ, Goodman AM, Kato S, Ellison CK, Daniels GA, Kim L, Nakashe P, McCarthy E, Mazloom AR, McLennan G, Grosu DS, Ehrich M, Kurzrock R. Jensen TJ, et al. Among authors: kim l. Mol Cancer Ther. 2019 Feb;18(2):448-458. doi: 10.1158/1535-7163.MCT-18-0535. Epub 2018 Dec 6. Mol Cancer Ther. 2019. PMID: 30523049
Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible.
Jensen TJ, Goodman AM, Ellison CK, Holden KA, Kato S, Kim L, Daniels GA, Fitzgerald K, McCarthy E, Nakashe P, Mazloom AR, Almasri E, McLennan G, Grosu DS, Eisenberg M, Kurzrock R. Jensen TJ, et al. Among authors: kim l. Mol Cancer Ther. 2021 Nov;20(11):2274-2279. doi: 10.1158/1535-7163.MCT-20-1066. Epub 2021 Aug 31. Mol Cancer Ther. 2021. PMID: 34465593 Free PMC article.
Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials.
Galanina N, Bejar R, Choi M, Goodman A, Wieduwilt M, Mulroney C, Kim L, Yeerna H, Tamayo P, Vergilio JA, Mughal TI, Miller V, Jamieson C, Kurzrock R. Galanina N, et al. Among authors: kim l. Cancers (Basel). 2018 Dec 21;11(1):11. doi: 10.3390/cancers11010011. Cancers (Basel). 2018. PMID: 30583461 Free PMC article.
Serial changes in liquid biopsy-derived variant allele frequency predict immune checkpoint inhibitor responsiveness in the pan-cancer setting.
Kato S, Li B, Adashek JJ, Cha SW, Bianchi-Frias D, Qian D, Kim L, So TW, Mitchell M, Kamei N, Hoiness R, Hoo J, Gray PN, Iyama T, Kashiwagi M, Lu HM, Kurzrock R. Kato S, et al. Among authors: kim l. Oncoimmunology. 2022 Mar 29;11(1):2052410. doi: 10.1080/2162402X.2022.2052410. eCollection 2022. Oncoimmunology. 2022. PMID: 35371621 Free PMC article.
Author Correction: Disrupting cellular memory to overcome drug resistance.
Harmange G, Hueros RAR, Schaff DL, Emert B, Saint-Antoine M, Kim LC, Niu Z, Nellore S, Fane ME, Alicea GM, Weeraratna AT, Simon MC, Singh A, Shaffer SM. Harmange G, et al. Among authors: kim lc. Nat Commun. 2024 May 20;15(1):4264. doi: 10.1038/s41467-024-48797-x. Nat Commun. 2024. PMID: 38769307 Free PMC article. No abstract available.
Diffractive mirrors for neutral-atom matter-wave optics.
Kim LY, Kang DW, Park S, Lim S, Kim J, Schöllkopf W, Zhao BS. Kim LY, et al. Faraday Discuss. 2024 May 20. doi: 10.1039/d3fd00155e. Online ahead of print. Faraday Discuss. 2024. PMID: 38766945
2,593 results